Javier Pérez-Pallarés
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Javier Pérez-Pallarés has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
Alexander Ali Jiménez Romero
1 shared publication- Borja Recalde-Zamacona
Pulmonary Medicine Department, Clinica Universidad de Navarra, Pamplona, Spain
1 shared publication - Borja Suberviola
Intensive Care Department, Hospital Marques de Valdecilla, Santander, Spain
1 shared publication - Carolina Garcia-Vidal
Department of Infectious Diseases, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain
1 shared publication - Cristina Pitart
Department of Medicine, Faculty of Medicine, University of Barcelona, 08036 Barcelona, Spain
1 shared publication - Deisy Barrios-Barreto
Hospital Universitario Ramon y Cajal, Madrid, Spain
1 shared publication
Latest Publications
- Open Access
- 14 October 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (20) , 6526
Ten Issues to Update in Nosocomial or Hospital-Acquired Pneumonia: An Expert Review
Nosocomial pneumonia, or hospital-acquired pneumonia (HAP), and ventilator-associated pneumonia (VAP) are important health problems worldwide, with both being associated with substantial morbidity and mortality. HAP is currently the main cause of death from nosocomial infection in critically ill patients. Although guidelines for the approach to this infection model are widely implemented in international health systems and clinical teams, information continually emerges that generates debate or requires updating in its management. This scientific manuscript, written by a multidisciplinary team of specialists, reviews the most important issues in the approach to this important infectious respiratory syndrome, and it updates various topics, such as a renewed etiological perspective for updating the use of new molecular platforms or imaging techniques, including the microbiological diagnostic stewardship in different clinical settings and using appropriate rapid techniques on invasive respiratory specimens. It also reviews both Intensive Care Unit admission criteria and those of clinical stability to discharge, as well as those of therapeutic failure and rescue treatment options. An update on antibiotic therapy in the context of bacterial multiresistance, in aerosol inhaled treatment options, oxygen therapy, or ventilatory support, is presented. It also analyzes the out-of-hospital management of nosocomial pneumonia requiring complete antibiotic therapy externally on an outpatient basis, as well as the main factors for readmission and an approach to management in the emergency department. Finally, the main strategies for prevention and prophylactic measures, many of them still controversial, on fragile and vulnerable hosts are reviewed.
- 14 October 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (20) , 6526
Open AccessTen Issues to Update in Nosocomial or Hospital-Acquired Pneumonia: An Expert Review
Nosocomial pneumonia, or hospital-acquired pneumonia (HAP), and ventilator-associated pneumonia (VAP) are important health problems worldwide, with both being associated with substantial morbidity and mortality. HAP is currently the main cause of death from nosocomial infection in critically ill patients. Although guidelines for the approach to this infection model are widely implemented in international health systems and clinical teams, information continually emerges that generates debate or requires updating in its management. This scientific manuscript, written by a multidisciplinary team of specialists, reviews the most important issues in the approach to this important infectious respiratory syndrome, and it updates various topics, such as a renewed etiological perspective for updating the use of new molecular platforms or imaging techniques, including the microbiological diagnostic stewardship in different clinical settings and using appropriate rapid techniques on invasive respiratory specimens. It also reviews both Intensive Care Unit admission criteria and those of clinical stability to discharge, as well as those of therapeutic failure and rescue treatment options. An update on antibiotic therapy in the context of bacterial multiresistance, in aerosol inhaled treatment options, oxygen therapy, or ventilatory support, is presented. It also analyzes the out-of-hospital management of nosocomial pneumonia requiring complete antibiotic therapy externally on an outpatient basis, as well as the main factors for readmission and an approach to management in the emergency department. Finally, the main strategies for prevention and prophylactic measures, many of them still controversial, on fragile and vulnerable hosts are reviewed.
- 24 June 2023
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 59 (9) , 566-574
Efficacy and Safety of Indwelling Catheter for Malignant Pleural Effusions Related to Timing of Cancer Therapy: A Systematic Review
- 24 June 2023
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 59 (9) , 566-574
Efficacy and Safety of Indwelling Catheter for Malignant Pleural Effusions Related to Timing of Cancer Therapy: A Systematic Review
- Open Access
- 28 December 2022
- Published by Instituto Mexicano del Seguro Social in Revista de Patología Respiratoria
- Vol. 25 (4) , 117-118
CRYOEBUS
- 28 December 2022
- Published by Instituto Mexicano del Seguro Social in Revista de Patología Respiratoria
- Vol. 25 (4) , 117-118
Open AccessCRYOEBUS
- Open Access
- 22 April 2022
- Published by Sociedad Espanola de Quimioterapia in Revista Española de Quimioterapia
- Vol. 35 (Suppl1) , 21-24
Usefulness of thoracic ultrasound for diagnosis and follow-up of pneumonia
Classically the diagnosis of both bacterial and viral pneumonias was made with chest radiology, later the use of chest CT was implemented, however in recent years lung ultrasound has become very important in the diagnosis of pulmonary pathology and increased in pandemic by SARS-CoV-2, due to the practicality of being done at the patient’s bedside, the ability to be reproducible, and the decrease in radiation exposure to patients.
- 22 April 2022
- Published by Sociedad Espanola de Quimioterapia in Revista Española de Quimioterapia
- Vol. 35 (Suppl1) , 21-24
Open AccessUsefulness of thoracic ultrasound for diagnosis and follow-up of pneumonia
Classically the diagnosis of both bacterial and viral pneumonias was made with chest radiology, later the use of chest CT was implemented, however in recent years lung ultrasound has become very important in the diagnosis of pulmonary pathology and increased in pandemic by SARS-CoV-2, due to the practicality of being done at the patient’s bedside, the ability to be reproducible, and the decrease in radiation exposure to patients.